Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery

Regenerative Medicine
Rebecca K Rowntree, John D McNeish

Abstract

Pluripotent embryonic stem cells (ESCs), when compared with transformed, primary or engineered cells, have unique characteristics and advantages that have resulted in the development of important cell-based tools in modern drug discovery. However, a key limitation has been the availability of human ESCs from patients with specific medical needs and the broad range of genetic variation represented worldwide. Induced pluripotent stem (iPS) cells are derived from somatic cells that are reprogrammed to a pluripotent stem cell state and have functional characteristics similar to ESCs. The demonstration that human iPS cells can be derived, with relative ease, through the introduction of transcription factor combinations has allowed the generation of disease-specific iPS cell lines. Therefore, iPS cell technology may deliver robust, human pluripotent cell lines from a wide range of clinical phenotypes and genotypes. Although human iPS cell technology is still a new tool in drug discovery, the promise that this technology will impact the discovery of new therapies can be projected based on the uptake of stem cell applications in biopharmaceutical sciences. Here, the near-term opportunities that iPS cells may deliver to drug discoverers...Continue Reading

References

Jan 17, 2002·The New England Journal of Medicine·H V HuikuriR J Myerburg
Feb 11, 2003·Nature Biotechnology·Thomas P Zwaka, James A Thomson
Mar 20, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Thorsten Gorba, Timothy E Allsopp
Jan 7, 2004·Nature Reviews. Drug Discovery·John McNeish
Aug 25, 2006·Nature Methods·David E RootDavid M Sabatini
Oct 21, 2006·Nature Biotechnology·Kevin A D'AmourEmmanuel E Baetge
Aug 2, 2007·Nature Reviews. Drug Discovery·Colin W Pouton, John M Haynes
Aug 8, 2007·Current Opinion in Pharmacology·John D McNeish
Nov 22, 2007·Science·Junying YuJames A Thomson
Dec 7, 2007·Chemical Research in Toxicology·F Peter Guengerich
Feb 19, 2008·Nature Biotechnology·Kenji OsafuneDouglas A Melton
Mar 26, 2008·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Jennifer A PaquetteDonald B Stedman
Aug 2, 2008·Stem Cells·Maureen L Condic, Mahendra Rao
Sep 27, 2008·Science·Matthias StadtfeldKonrad Hochedlinger
Oct 11, 2008·Science·Keisuke OkitaShinya Yamanaka
Oct 22, 2008·Nature Biotechnology·Trond AasenJuan Carlos Izpisúa Belmonte
Dec 23, 2008·Nature·Allison D EbertClive N Svendsen
Mar 17, 2009·Stem Cells and Development·Kitchener D WilsonJoseph C Wu
Apr 21, 2009·The Journal of Biological Chemistry·Miguel A EstebanDuanqing Pei
Apr 29, 2009·Cell Stem Cell·Hongyan ZhouSheng Ding
May 16, 2009·Expert Opinion on Drug Metabolism & Toxicology·Judith K GwathmeyRoger J Hajjar
May 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Costas A LyssiotisRudolf Jaenisch
Jun 9, 2009·Journal of Molecular Cell Biology·Zhao WuLei Xiao
Jun 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Toshihiko EzashiR Michael Roberts
Jun 23, 2009·EMBO Reports·Alan Colman, Oliver Dreesen
Jul 4, 2009·Reproductive Biomedicine Online·Jonathan C NiclisDavid S Cram
Jul 21, 2009·Biochemical and Biophysical Research Communications·Noritaka YokooToshio Heike

❮ Previous
Next ❯

Citations

Jan 13, 2011·Archives of Toxicology·Anna M Wobus, Peter Löser
Feb 9, 2012·Child and Adolescent Psychiatry and Mental Health·John S March, Joerg M Fegert
Aug 1, 2014·Journal of Cellular Biochemistry·Achim Rosemann
Mar 18, 2011·Journal of Child Psychology and Psychiatry, and Allied Disciplines·James F Leckman, John S March
Sep 25, 2012·Current Opinion in Cell Biology·Guang-Hui LiuJuan Carlos Izpisua Belmonte
Jun 12, 2013·Cell Stem Cell·Sandra J Engle, Dinesh Puppala
Dec 3, 2014·Drug Discovery Today·Nadia K Litterman, Sean Ekins
Jul 17, 2010·Regenerative Medicine·M William Lensch, Mahendra Rao
Mar 15, 2012·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Hyun-Jung Kim, Chang Yun Jin
May 24, 2014·Expert Review of Neurotherapeutics·Jacob S YoungMaciej S Lesniak
Feb 2, 2016·Current Protocols in Toxicology·Marc C HanselStephen C Strom
Feb 26, 2014·Stem Cell Research & Therapy·Zongyou GuoAngela M Christiano

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
transgenic
metabolomic profiling
SMA
pharmacotherapy
genetic modification
genetic modifications

Software Mentioned

iCell

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.